Wednesday, October 7, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 3, 2026

IAMGOLD and OneSpaWorld have been highlighted as Zacks Bull and Bear of the Day

View original at finance.yahoo.com
IAMGOLD and OneSpaWorld have been highlighted as Zacks Bull and Bear of the Day For Immediate Release Chicago, IL – March 3, 2026 – Zacks Equity Research shares IAMGOLD IAG as the Bull of the Day and OneSpaWorld OSW as the Bear of the Day…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • When gold prices rise, margins expand fast due to high fixed costs in mining

    80% confidence
  • MetaMask Card allows users to spend directly from wallets without preloading funds onto centralized exchanges with assets remaining in users' control until transaction moment

    80% confidence
  • Mastercard partnership with MetaMask reinforces strategy of embedding deeper into digital asset ecosystem without taking balance sheet crypto risk

    80% confidence
  • New York regulatory clarity reduces friction and broadens addressable user base for crypto-linked cards

    80% confidence
  • Gold mining stocks are some of the best performing ones out there

    80% confidence
  • OneSpaWorld's spa treatments on cruises are discretionary squared, among first expenses cut when consumer confidence wobbles

    80% confidence
  • IAMGOLD is transitioning from rebuild mode to cash flow mode

    80% confidence
  • Gold prices have been living in record territory

    80% confidence
  • If adoption scales meaningfully, crypto-linked debit could drive incremental payment volume through Mastercard's network

    80% confidence
  • OneSpaWorld concentration risk in cruise lines becomes glaring when macro uncertainty increases

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,362 source documents archived
Query this data → isubstrate.com
IAMGOLD and OneSpaWorld have been highlighted as Zacks Bull and Bear of the Day — Source | Via News | ViaNews Market